TCRT
Alaunos Therapeutics, Inc. Common Stock
stockNASDAQ
At CloseOct 13, 2026 3:59:59 PM EDT
3.02USD+187.143%(+1.97)245,216,544
Pre-marketOct 13, 2026 9:29:48 AM EDT
1.73USD+64.762%(+0.68)
After-hoursOct 13, 2026 4:47:30 PM EDT
3.318USD+10.050%(+0.303)
Loading…
Loading…
7.72M
Healthcare
Biotechnology
HQ
Houston, TX, USA
Previous Close
$1.05
Beta
1.35
52-Week High
$4.50 2025-12-12
52-Week Low
$0.72 2026-10-06
SMA 50
$1.49
SMA 200
$2.38
Avg. Vol 10D
439,218
Avg. Vol 30D
1.80M
Avg. Vol 90D
610,790
Relative Vol
93.76
2.54M
1.87M
73.47%
9,736
0.52%
1.00
39%/61%
55.44%
49.71%
81.2100%
6,915
6,915
6,915
Nov 13, 2026 (31d)
Jul 18, 2024 · 1-for-10 (reverse)
Oct 13, 2026
Alaunos Therapeutics Announces Acquisition of Velaris Therapeutics · 
GlobeNewswire Inc.
Sep 18, 2026
Alaunos Therapeutics raises $1.12M in registered direct offering · 
Investing.com
TCRT Profile
ziopharm oncology, inc., is a biopharmaceutical company focused on the discovery and development of new cancer therapies. we are applying the latest technologies in cancer research to develop safer, more precise therapeutics to improve care and quality of life for patients.
TCRT Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.74 | 2026-10-06 | +309.45% | -1.037 |
| 1M | 1.49 | 2026-09-14 | +104.03% | 6.269 |
| 3M | 2.08 | 2026-07-13 | +45.87% | 1.920 |
| 6M | 2.96 | 2026-04-13 | +2.70% | 1.806 |
| 1Y | 3.26 | 2025-10-13 | -6.75% | 1.346 |
| 2Y | 2.08 | 2024-10-14 | +46.15% | — |
| 5Y | 135.00 | 2022-01-28 | -97.75% | 1.110 |
TCRT Stock Summary
Alaunos Therapeutics, Inc. Common Stock (NASDAQ:TCRT) stock price today is $3.04, and today's volume is 169,172,929. TCRT is up 189.524% today. The 30 day average volume is 1.80M. TCRT market cap is $7.72M with 2.54M shares outstanding.